In an adult with a history of cerebrovascular accident who has nightly recurrent fever followed by profuse sweating, how can I distinguish infection-related fever from central neurogenic fever and what is the appropriate work‑up and management?

Distinguishing Central Neurogenic Fever from Infectious Fever in Post-Stroke Patients

In an adult with prior stroke presenting with nightly recurrent fever and profuse sweating, you should strongly suspect central neurogenic fever if the fever began within 72 hours of the neurological event, occurs without infiltrate on chest X-ray, and inflammatory markers (CRP, procalcitonin, WBC) remain normal—but you must still complete a full infectious work-up before making this diagnosis of exclusion. 1, 2, 3

Immediate Diagnostic Approach

Rule Out Infection First (Mandatory)

Central fever remains a diagnosis of exclusion; premature treatment while missing an infection can worsen outcomes. 1 You must systematically investigate infectious sources:

• Obtain at least two sets of blood cultures (60 mL total) to identify bacteremia 1, 4, 5
• Perform chest radiograph for all patients with new fever to evaluate for pneumonia 1, 4, 5, 3
• Measure inflammatory markers: CRP, procalcitonin, and complete blood count with differential 2, 6
• Consider CT imaging if there is recent surgery or abdominal/pelvic symptoms 1
• Lumbar puncture only if neurologically appropriate and not contraindicated by elevated intracranial pressure 1, 5
• Urinalysis and urine culture, especially if urinary catheter is present 7

Key Clinical Indicators That Favor Central Fever

The following features strongly predict central neurogenic fever over infectious causes:

Timing Characteristics

• Fever onset within 72 hours of stroke admission (odds ratio 2.20; 95% CI 1.23-3.94) 3
• Earlier onset than infectious fever: median day 2 (range 1-3) versus day 6 (range 4-9) for infection 2, 7
• Persistent fever pattern lasting >6 hours for 2+ consecutive days (26.4% in central vs 18.6% in infectious fever) 3

Anatomical Localization

• Left hypothalamic region involvement (odds ratio 9.7; 95% CI 1.6-58.8) is the strongest independent predictor 2
• Left midbrain lesions are significantly associated with central fever 2
• Intraventricular hemorrhage or subarachnoid hemorrhage diagnosis (odds ratio 6.33; 95% CI 3.72-10.77) 3
• Mass effect or transtentorial herniation on imaging 7

Laboratory Profile

• Normal or minimally elevated inflammatory markers (CRP, procalcitonin, WBC) despite fever 2, 6, 8
• Absence of cultured pathogens after appropriate investigation 2, 3
• No infiltrate on chest X-ray (odds ratio 3.02; 95% CI 1.81-5.05) 3

Clinical Severity Markers

• Higher NIHSS scores and worse neurological status 2
• Lower Glasgow Coma Scale scores on admission 7
• Recent blood transfusion (odds ratio 3.06; 95% CI 1.63-5.76) 3

Predictive Model for Central Fever

When you observe the combination of: (1) negative cultures, (2) no infiltrate on chest X-ray, (3) diagnosis of subarachnoid hemorrhage/intraventricular hemorrhage/tumor, and (4) fever onset within 72 hours of admission—the probability of central fever is 0.90. 3

Temperature Management Protocol

Immediate Treatment Regardless of Etiology

Do not delay antipyretic treatment while searching for the fever source—fever duration directly correlates with worse outcomes in stroke patients, and uncontrolled fever precipitates secondary brain injury regardless of whether it is infectious or neurogenic. 1, 4, 5

Target Temperature Parameters

• Maintain core temperature 36.0–37.5°C 1, 4, 5
• Avoid temperature variation exceeding ±0.5°C per hour or 1°C per 24 hours 1, 4

First-Line Pharmacologic Management

• Administer acetaminophen (paracetamol) immediately as first-line antipyretic 1, 4, 5
• Consider NSAIDs as alternative first-line agents if acetaminophen is insufficient 4, 5
• Recognize that antipyretics have limited efficacy in severe brain injury and central fever 1, 4

Advanced Temperature Control

• Implement automated feedback-controlled temperature management devices if fever persists despite pharmacologic therapy 1, 4, 5
• These devices are superior to antipyretics alone for achieving target temperature control in severe neurological injury 1

Temperature Monitoring Strategy

• Use central temperature monitoring when available: bladder catheter, esophageal thermistor, or pulmonary artery catheter 1, 4, 5
• When central monitoring unavailable, use oral or rectal temperatures rather than axillary or tympanic measurements 1, 5
• Continuous monitoring is preferable to intermittent measurements 5

Distinguishing Features: Central vs. Infectious Fever

Feature	Central Fever	Infectious Fever
Onset timing	Within 72 hours of stroke [2,7,3]	Later onset (median day 6) [2,7]
Fever pattern	Persistent, non-cyclic [1]	May be intermittent [6]
Inflammatory markers	Normal or minimally elevated [2,6,8]	Elevated CRP, procalcitonin, WBC [2]
Chest X-ray	No infiltrate [3]	May show infiltrate [3]
Cultures	Negative [2,3]	Positive pathogenic growth [3]
Anatomical location	Hypothalamus, midbrain, IVH [2,3]	No specific pattern [7]
Response to antibiotics	No response [6]	Responds to appropriate therapy [6]

Critical Management Considerations

When to Suspect Central Fever Specifically

The nightly pattern with profuse sweating you describe is consistent with autonomic dysregulation from hypothalamic injury. 8 Central fever characteristically shows:

• Core temperature >37.5°C without evidence of sepsis or clinically significant inflammatory processes 1
• Persistent elevation without cyclic pattern 1
• Autonomic symptoms including sweating, which reflects thermoregulatory dysfunction 8

Common Pitfalls to Avoid

• Do not attribute fever to central causes prematurely—infection must be ruled out first, as infectious fever is more common (53.3% vs 46.8% in neurologic ICU patients) 3
• Do not withhold antipyretics while awaiting culture results—the neuroprotective benefit of early normothermia outweighs diagnostic delays 1
• Do not use therapeutic hypothermia (32-35°C) in acute stroke with fever—moderate hypothermia worsened functional outcomes in the Eurotherm3235 trial (adjusted OR 1.53; 95% CI 1.02-2.30) 1
• Elderly patients and immunosuppressed individuals may have blunted fever responses despite serious infection 1

ICU-Level Care Requirements

All management should occur in an ICU setting given the high acuity, frequent need for intracranial pressure monitoring, potential need for mechanical ventilation, and multiple medical complications. 4, 5 The combination of hyperthermia and intracranial hypertension has stronger predictive value for poor neurological outcomes than either condition alone. 4

Duration of Treatment

Maintain controlled normothermia for the entire period the brain is vulnerable to secondary injury, typically throughout the acute phase when patients remain at risk. 1 Continue temperature management even after infectious sources are ruled out, as central fever itself causes harm through increased metabolic demands, enhanced excitatory neurotransmitter release, increased free radical production, and elevated intracranial pressure. 1, 4